Page 1 | Search Results | Blood Advances | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-1 of 1

Sort by

Sort Order Select

Journal Articles

Cost-effectiveness of second-line lisocabtagene maraleucel in relapsed or refractory diffuse large B-cell lymphoma

Jee H. Choe, Tianzhou Yu, Jeremy S. Abramson, Mohamed Abou-el-Enein

Blood Adv (2024) 8 (2): 484–496.

https://doi.org/10.1182/bloodadvances.2023011793

Published: 2024

Includes: Supplemental data